Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enhanced T-helper cell function following CD4 modulation

W J Morrison1, H Offner, A A Vandenbark

  • 1Neuroimmunology Research Laboratory, Veterans Administration Medical Center, Portland, Oregon 97201.

Cellular Immunology
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.

Neuroscience·2015
Same author

Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.

Mucosal immunology·2010
Same author

Effect of serum on the isolated CNS myelin membrane.

Neurochemistry international·2010
Same author

Density distribution of myelin fragments isolated from control and multiple sclerosis brains.

Neurochemistry international·2010
Same author

Myelin changes induced by incubation of brain slices with serum.

Neurochemistry international·2010
Same author

Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis.

Journal of neuroimmunology·2010
Same journal

The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitro.

Cellular immunology·2026
Same journal

Exosome-mediated immune modulation in rheumatoid arthritis and its role in synovial inflammation and autoimmune amplification.

Cellular immunology·2026
Same journal

Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Cellular immunology·2026
Same journal

Deficit in blood MAIT cells, altered cytokines and T cell dynamics in patients with coronary artery disease.

Cellular immunology·2026
Same journal

The circ_0003692-miR-1197-TLR4 axis: A key regulator in rheumatoid arthritis proliferation and inflammation.

Cellular immunology·2026
Same journal

IGF2BP2 promotes cuproptosis of cardiomyocytes through m<sup>6</sup>A modification of MAP2K1 in sepsis-induced myocardial injury.

Cellular immunology·2026
See all related articles

Selective reduction of CD4+ T cells using ganglioside (GM1) or antisense oligodeoxynucleotides enhances T cell proliferation and delayed-type hypersensitivity responses to recall antigens.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD4+ T cells play a crucial role in adaptive immunity.
  • Modulating CD4+ T cell surface expression can impact immune responses.

Purpose of the Study:

  • To investigate the effects of selectively decreasing CD4+ T cell surface expression on T cell proliferation and delayed-type hypersensitivity (DTH).
  • To compare the mechanisms of CD4+ T cell modulation by ganglioside (GM1) and antisense oligodeoxynucleotides.

Main Methods:

  • T cells were treated with ganglioside (GM1) or antisense oligodeoxynucleotides targeting CD4 mRNA.
  • CD4 levels were quantified.
  • Northern blot analysis was performed to assess CD4 mRNA production.
  • T cell proliferation and DTH responses were measured upon challenge with recall antigen.

Related Experiment Videos

Main Results:

  • Antisense treatment reduced CD4 levels by 45% but did not alter the duration of CD4 modulation induced by GM1.
  • Ganglioside modulation did not affect CD4 mRNA levels, distinguishing it from antisense modulation.
  • Both GM1 and antisense-induced CD4 modulation led to increased T cell proliferation and enhanced DTH responses.

Conclusions:

  • Selective reduction of cell surface CD4 enhances antigen-specific T cell responses.
  • GM1 and antisense oligodeoxynucleotides modulate CD4+ T cells through distinct mechanisms.
  • Decreasing CD4+ T cell expression is a potential strategy to boost T cell-mediated immunity.